Acanthocytosis and neurological disorders

被引:0
|
作者
Valerie L. Stevenson
Richard J. Hardie
机构
[1] Department of Neurology,
[2] Atkinson Morley's Hospital,undefined
[3] Copse Hill,undefined
[4] Wimbledon,undefined
[5] London,undefined
[6] SW20 0NE,undefined
[7] UK,undefined
[8] Tel.: +44-20-87 25 47 65,undefined
[9] Fax: +44-20-89 44 99 27,undefined
[10] e-mail: rhardie@sghms.ac.uk,undefined
来源
Journal of Neurology | 2001年 / 248卷
关键词
Key words Acanthocytes; Neuroacanthocytosis; Abetalipoproteinaemia; McLeod syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Acanthocytosis occurs because of ultrastructural abnormalities of the erythrocyte membranous skeleton resulting in reduced membrane fluidity. At least three hereditary neurological conditions are associated with it, although as yet the pathogenesis of the neurological features is unknown. In abetalipoproteinaemia, an autosomal recessive condition, vitamin E deficiency results in a progressive spinocerebellar syndrome associated with peripheral neuropathy and retinitis pigmentosa. Neuroacanthocytosis is also probably an autosomal recessive condition and is characterised by chorea, orofaciolingual dyskinesia, dysarthria, areflexia, seizures and dementia. McLeod syndrome is an X-linked recessive disorder usually presneting in males as a benign myopathy within areflexia, in association with a particular abnormality of expression of Kell blood group antigens. However, occasionally the neurological features are more severe and indistinguishable from those of neuroacanthocytosis. Recent advances in molecular genetics may assist better understanding of the disease mechanisms and the search for more effective treatment.
引用
收藏
页码:87 / 94
页数:7
相关论文
共 50 条
  • [41] Dysthymia in neurological disorders
    Akiskal, HS
    Bolis, CL
    Cazzullo, C
    Silva, JACE
    Gentil, V
    Lecrubier, Y
    Licinio, J
    Linden, M
    LopezIbor, JJ
    Ndiaye, IP
    Pani, L
    Prilipko, L
    Robertson, MM
    Robinson, RG
    Starkstein, SE
    Thomas, P
    Wang, Y
    Wong, ML
    MOLECULAR PSYCHIATRY, 1996, 1 (06) : 478 - 491
  • [42] Nutraceuticals in Neurological Disorders
    Makkar, Rashita
    Behl, Tapan
    Bungau, Simona
    Zengin, Gokhan
    Mehta, Vineet
    Kumar, Arun
    Uddin, Md. Sahab
    Ashraf, Ghulam Md.
    Abdel-Daim, Mohamed M.
    Arora, Sandeep
    Oancea, Roxana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 19
  • [43] Apheresis in Neurological Disorders
    Dorst, Johannes
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10)
  • [44] Neurological disorders and mitochondria
    Cabral-Costa, J. V.
    Kowaltowski, A. J.
    MOLECULAR ASPECTS OF MEDICINE, 2020, 71
  • [45] Inclusion with Neurological Disorders
    Wallesch, Claus-W.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2013, 81 (02) : 67 - 68
  • [46] Genomics in Neurological Disorders
    Guangchun Han
    Jiya Sun
    Jiajia Wang
    Zhouxian Bai
    Fuhai Song
    Hongxing Lei
    Genomics,Proteomics & Bioinformatics, 2014, (04) : 156 - 163
  • [47] Plasmapheresis for neurological disorders
    Schroeder, Alexandra
    Linker, Ralf A.
    Gold, Ralf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (09) : 1331 - 1339
  • [48] NEUROLOGICAL DISORDERS IN INSULOMA
    KOSTINA, ZP
    SELIVANOVA, IG
    SKOROMETS, AA
    ULITSKY, LA
    SOVETSKAYA MEDITSINA, 1978, (03): : 78 - 81
  • [49] Neurological Disorders in Pregnancy
    Shehata, Hassan A.
    Gupta, Sahana
    CURRENT WOMENS HEALTH REVIEWS, 2011, 7 (02) : 217 - 225
  • [50] Nanotherapeutics for Neurological Disorders
    Baboota, Sanjula
    Ali, Javed
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (19) : 2193 - 2194